219 related articles for article (PubMed ID: 27083054)
1. Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.
Stringer BW; Bunt J; Day BW; Barry G; Jamieson PR; Ensbey KS; Bruce ZC; Goasdoué K; Vidal H; Charmsaz S; Smith FM; Cooper LT; Piper M; Boyd AW; Richards LJ
Oncotarget; 2016 May; 7(20):29306-20. PubMed ID: 27083054
[TBL] [Abstract][Full Text] [Related]
2. Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.
Chen KS; Bridges CR; Lynton Z; Lim JWC; Stringer BW; Rajagopal R; Wong KT; Ganesan D; Ariffin H; Day BW; Richards LJ; Bunt J
J Neurooncol; 2020 Jan; 146(1):41-53. PubMed ID: 31760595
[TBL] [Abstract][Full Text] [Related]
3. A positive feedback loop involving nuclear factor IB and calpain 1 suppresses glioblastoma cell migration.
Vo TM; Jain S; Burchett R; Monckton EA; Godbout R
J Biol Chem; 2019 Aug; 294(34):12638-12654. PubMed ID: 31262726
[TBL] [Abstract][Full Text] [Related]
4. NFIA and NFIB function as tumour suppressors in high-grade glioma in mice.
Chen KS; Lynton Z; Lim JWC; Robertson T; Gronostajski RM; Bunt J; Richards LJ
Carcinogenesis; 2021 Apr; 42(3):357-368. PubMed ID: 33346791
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
6. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.
Brun M; Jain S; Monckton EA; Godbout R
Neoplasia; 2018 Oct; 20(10):1023-1037. PubMed ID: 30195713
[TBL] [Abstract][Full Text] [Related]
8. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
9. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
10. The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis.
Ferreyra Solari NE; Belforte FS; Canedo L; Videla-Richardson GA; Espinosa JM; Rossi M; Serna E; Riudavets MA; Martinetto H; Sevlever G; Perez-Castro C
Cancer Res; 2016 Sep; 76(18):5383-94. PubMed ID: 27406830
[TBL] [Abstract][Full Text] [Related]
11. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.
Becker-Santos DD; Lonergan KM; Gronostajski RM; Lam WL
EBioMedicine; 2017 Aug; 22():2-9. PubMed ID: 28596133
[TBL] [Abstract][Full Text] [Related]
13. SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling.
Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang X; Wang C
Biochem Biophys Res Commun; 2021 Mar; 544():73-80. PubMed ID: 33524871
[TBL] [Abstract][Full Text] [Related]
14. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma.
Yu H; Zhang D; Li Z; Wang M
Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494
[TBL] [Abstract][Full Text] [Related]
15. TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling.
Qiang Z; Jun-Jie L; Hai W; Hong L; Bing-Xi L; Lei C; Wei X; Ya-Wei L; Huang A; Song-Tao Q; Yun-Tao L
Carcinogenesis; 2018 Feb; 39(2):214-224. PubMed ID: 29106517
[TBL] [Abstract][Full Text] [Related]
16. The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma.
Jin UH; Karki K; Cheng Y; Michelhaugh SK; Mittal S; Safe S
J Biol Chem; 2019 Jul; 294(29):11342-11353. PubMed ID: 31171720
[TBL] [Abstract][Full Text] [Related]
17. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
[TBL] [Abstract][Full Text] [Related]
18. SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis.
Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang C
Biochem Biophys Res Commun; 2021 Apr; 547():148-154. PubMed ID: 33610914
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal models.
Rouland L; Duplan E; Ramos Dos Santos L; Bernardin A; Katula KS; Manfioletti G; Idbaih A; Checler F; Alves da Costa C
Theranostics; 2021; 11(20):10047-10063. PubMed ID: 34815803
[TBL] [Abstract][Full Text] [Related]
20. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
